Genmab A/s Stock Performance
as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
$30.1$30.53
0.56%
Downside
0.86%
Upside
52 Week's Low
52 Week's High
$17.24$33.6543.06%
Downside
11.17%
Upside
Genmab A/s share price movements today
- Previous Close
- $30.24
- Open
- $30.14
- Volume
- 1.5M
- Day's Low - High
- $30.1 - $30.53
- 52 Week Low - High
- $17.24 - $33.65
Genmab A/s Historical Returns
- 1 Month Return
- -7.66 %
- 3 Month Return
- + 31.59 %
- 1 Year Return
- + 42.78 %
- 3 Year Return
- -28.91 %
- 5 Year Return
- -16.51 %
Genmab A/s Stock Fundamentals & Key Indicators
Check Genmab A/s market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$18.8B
EPS (TTM)
1.8812
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.08%
PE Ratio (TTM)
13.31
Industry PE ratio
19.200384615384614
PEG Ratio
0.7564
EBITDA
1.5B
Revenue (TTM)
3.8B
Profit Margin
41.17%
Return On Equity TTM
29.41%
Genmab A/s Stock Valuation
Track how Genmab A/s P/E has moved over time to understand its valuation trends.
Genmab A/s in the last 5 years
Lowest (4.59x)
December 31, 2020
Today (13.31x)
November 14, 2025
Industry (19.20x)
November 14, 2025
Highest (64.13x)
September 30, 2021
Today’s Price to Earnings Ratio: 13.31x
Genmab A/s vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genmab A/s with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $18.8B | -16.51% | 13.31 | 41.17% | |
| BUY | $59.8B | 235.01% | 1414.81 | 1.36% | |
| NA | $40.9B | NA | 712.21 | 1.38% | |
| BUY | $110.2B | 92.67% | 30.58 | 31.35% | |
| BUY | $71.6B | 22.7% | 16.34 | 32.13% |
Stock Returns calculator for Genmab A/s Stock including INR - Dollar returns
The Genmab A/s stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Genmab A/s investment value today
Current value as on today
₹1,48,041
Returns
₹48,041
(+48.04%)
Returns from Genmab A/s Stock
₹42,918 (+42.92%)
Dollar Returns*
₹5,123 (+5.12%)
Analyst Recommendation on Genmab A/s Stock
Based on 31 analysts
61.29%
Buy
29.03%
Hold
9.68%
Sell
Based on 31 analysts, 61.29% of analysts recommend a 'BUY' rating for Genmab A/s. Average target price of $37.24
Genmab A/s Share Price Target
Get share price movements and forecasts by analysts on Genmab A/s.
What analysts predicted
18.72%UPSIDE
Target Price
$37.24
Current Price
$30.27
Analyzed by
31 Analysts
Target
$37.24
Genmab A/s target price $37.24, a slight upside of 18.72% compared to current price of $30.27. According to 31 analysts rating.
Genmab A/s Stock’s Investor Sentiment and Interest
Investment in Genmab A/s Shares on INDmoney has grown by 336.84% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:336.84% versus previous 30 day period
Search interest for Genmab A/s Stock has increased by 87% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:87% versus previous 30 day period
Genmab A/s Quarterly Profit & Loss
All numbers in Millions USD
Genmab A/s Annual Profit & Loss
All numbers in Millions USD
Genmab A/s Quarterly Cash Flow
All numbers in Millions USD
Genmab A/s Annual Cash Flow
All numbers in Millions USD
Genmab A/s News & Key Events
Today's Timeline - 06 November
Thu, 11:05 PM
-Genmab A/S reports Q3 earnings: sales up 25% to $1,022 million, net income rises to $401 million.
Insights on Genmab A/s
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, GMAB stock has moved up by 5.6%
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 93.3% return, outperforming this stock by 46.3%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 76.1% return, outperforming this stock by 105.9%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 5.86B → 1.02B (in $), with an average decrease of 82.6% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 2.12B → 401.0M (in $), with an average decrease of 81.2% per quarter
About Genmab A/s
| Organisation | Genmab A/s |
| Headquarters | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
| Industry | Health Technology |
| CEO | Dr. Jan G.J. van de Winkel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Genmab A/s
Name | Title |
|---|---|
Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
Mr. Takahiro Hamatani | Senior Director of Finance Japan & Non-Independent Director |
Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
Mr. Anthony Pagano CPA | Executive VP & CFO |
Mr. Christopher Cozic | Executive VP & Chief People Officer |
Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
Mr. Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director |
Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
Dr. Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director |
FAQs
What is Genmab A/s share price today?
Genmab A/s share price today is $30.27 as on at the close of the market. Genmab A/s share today touched a day high of $30.53 and a low of $30.1.
What is the 52 week high and 52 week low for Genmab A/s share?
Genmab A/s share touched a 52 week high of $33.65 on and a 52 week low of $17.24 on . Genmab A/s stock price today i.e. is closed at $30.27,which is 10.04% down from its 52 week high and 75.63% up from its 52 week low.
What is Genmab A/s's market capitalisation today?
Genmab A/s market capitalisation is $0.02T as on .
How to invest in Genmab A/s Stock (GMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Genmab A/s on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genmab A/s Shares that will get you 0.0496 shares as per Genmab A/s share price of $30.27 per share as on November 15, 2025 at 2:29 am IST.
What is the minimum amount required to buy Genmab A/s Stock (GMAB) from India?
Indian investors can start investing in Genmab A/s (GMAB) shares with as little as ₹88.64 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.40 in Genmab A/s stock (as per the Rupee-Dollar exchange rate as on ).
Based on Genmab A/s share’s latest price of $30.27 as on November 15, 2025 at 2:29 am IST, you will get 0.3304 shares of Genmab A/s. Learn more about
fractional shares .
What are the returns that Genmab A/s has given to Indian investors in the last 5 years?
Genmab A/s stock has given -16.51% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?